Lab-in-the-loop therapeutic antibody design with deep learning
2025 · bioRxiv (Cold Spring Harbor Laboratory) · 21 citations
https://doi.org/10.1101/2025.02.19.639050
S
Simon Kelow
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
17
Papers
167
Citations
8
h-index
7
i10-index
Simon Kelow is an academic researcher from Acentech (United States). The author has contributed to research in topics: Monoclonal and Polyclonal Antibodies Research & T-cell and B-cell Immunology & RNA and protein synthesis mechanisms. The author has an h-index of 8, co-authored 15 publications.
ORCID: 0000-0003-0692-7475Papers by this author
worksComputational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virus
2023 · Heliyon · 12 citations
https://doi.org/10.1016/j.heliyon.2023.e15032
Candidate variants in DNA replication and repair genes in early-onset renal cell carcinoma patients referred for germline testing
2023 · BMC Genomics · 2 citations
https://doi.org/10.1186/s12864-023-09310-8
Corrigendum to “Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virus” [Heliyon 9(4) (April 2023) e15032]
2023 · Heliyon · 0 citations
https://doi.org/10.1016/j.heliyon.2023.e17901
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat